CIDP (chronic inflammatory demyelinating polyneuropathy): open trials in Japan

• NCT05327114

  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 2/3 · Janssen Research & Development, LLC

  National Hospital Organization Asahikawa Medical Center, Asahikawa · Institute of Science Tokyo Hospital, Bunkyō City · Chiba University Hospital, Chiba · Seirei Hamamatsu General Hospital, Hamamatsu · Tokai University Hospital, Isehara · Kobe City Medical Center General Hospital, Kobe · National Center of Neurology and Psychiatry, Kodaira-shi · Saitama Medical Center, Koshigaya · Kumamoto University Hospital, Kumamoto · Nagoya University Hospital, Nagoya · Chubu Rosai Hospital, Nagoya · Kindai University Hospital, Osaka Sayama Shi · National Hospital Organization Sendai Medical Center, Sendai · Dokkyo Medical University Hospital, Shimotsuga-gun · Tokyo Women's Medical University Hospital, Shinjuku-ku · Tenri Hospital, Tenri · Ehime University Hospital, Toon-shi · Toyama University Hospital, Toyama · Yamaguchi University Hospital, Ube

  Registry updated 2026-11-03

• NCT06920004

  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  Aomori Prefectural Central Hospital, Aomori · Juntendo University Hospital, Bunkyō City · Chiba University Hospital, Chūōku · Seirei Hamamatsu Hospital, Hiroshima · Juntendo Shizuoka University Hospital, Izunokuni · Osaka Metropolitan University Hospital, Osaka · Saga University Hospital, Saga · Jichi Medical University Hospital, Shimotsuke · General Hospital Tsuchiura Kyodo Hospital, Tsuchiura · Yamaguchi University Hospital, Ube

  Registry updated 2026-11-03

• NCT06858579

  A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  Trial Treatment · Phase 3 · Dianthus Therapeutics

  Cinical Study Site, Chiba · Cinical Study Site, Hirakata · Cinical Study Site, Kawagoe · Cinical Study Site, Kawasaki · Cinical Study Site, Kurashiki · Cinical Study Site #2, Kyoto · Cinical Study Site, Nagoya · Cinical Study Site, Niigata · Cinical Study Site, Sapporo · Cinical Study Site, Tokyo · Cinical Study Site, Tsukuba · Cinical Study Site, Ube

  Registry updated 2026-10-28

• NCT06859099

  Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

  Trial Treatment · Phase 3 · Sanofi

  Investigational Site Number : 3920011, Bunkyo-Ku · Investigational Site Number : 3920012, Higashi-Matsuyama · Investigational Site Number : 3920008, Kodaira

  Registry updated 2026-10-27

• NCT07091630

  A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP

  Trial Treatment · Phase 3 · argenx

  Institute of Science Tokyo Hospital, Bunkyo-ku · Seirei Hamamatsu Hospital, Hiroshima · Southern TOHOKU Medical Clinic, Kōriyama · Saga University Hospital, Saga

  Registry updated 2026-10-27

• NCT06290141

  A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Trial Treatment · Phase 3 · Sanofi

  Investigational Site Number : 3920007, Amagasaki · Investigational Site Number : 3920001, Chiba · Investigational Site Number : 3920012, Higashi-Matsuyama · Investigational Site Number : 3920005, Kawagoe · Investigational Site Number : 3920008, Kodaira · Investigational Site Number : 3920010, Ōta-ku · Investigational Site Number : 3920009, Saga · Investigational Site Number : 3920014, Yaizu · Investigational Site Number : 3920015, Yokohama

  Registry updated 2026-10-19

All CIDP (chronic inflammatory demyelinating polyneuropathy) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error